Biological markers of Alzheimer's disease in cerebrospinal fluid: clinical and laboratory comparisons

Biological markers of Alzheimer's disease in cerebrospinal fluid: clinical and laboratory comparisons

Diagnostic hypothesis of Alzheimer's disease (AD) is based on the typical clinical picture of the disease and the exclusion of other diseases manifesting by cognitive and behavioural disorders by MRI scans of the brain and laboratory tests. For an accurate diagnosis of AD and exclusion of other...

Full description

Saved in:

Bibliographic Details
Main Authors:	K. V. Shevtsova, D. O. Rozhkov, D. A. Grishina, V. V. Grinyuk, V. V. Zakharov, N. M. Kashakanova, N. N. Koberskaya, O. V. Kosivtsova, A. B. Lokshina, Yu. A. Starchina, A. Yu. Tyurina, A. Yu. Fedorova, V. A. Parfenov
Format:	Article
Language:	Russian
Published:	IMA-PRESS LLC 2024-06-01
Series:	Неврология, нейропсихиатрия, психосоматика
Subjects:	alzheimer's disease biological markers of alzheimer's disease in cerebrospinal fluid hippocampal sclerosis anti-amyloid therapy
Online Access:	https://nnp.ima-press.net/nnp/article/view/2279
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Cerebrospinal Fluid Biomarkers of Alzheimer Disease
by: Kseniya V. Nevzorova, et al.
Published: (2025-06-01)

Cerebrospinal fluid amyloid beta and tau protein: Biomarkers for Alzheimer's disease
by: Mandić Gorana, et al.
Published: (2008-01-01)

Cerebrospinal fluid and plasma biomarker trajectories with increasing amyloid deposition in Alzheimer's disease
by: Sebastian Palmqvist, et al.
Published: (2019-11-01)

Clinical performance of the fully automated Lumipulse plasma p‐tau217 assay in mild cognitive impairment and mild dementia
by: Adam H. Dyer, et al.
Published: (2025-01-01)

Corrigendum: Differentiation of Alzheimer's disease from other neurodegenerative disorders using chemiluminescence immunoassays measuring cerebrospinal fluid biomarkers
by: Philipp Arendt, et al.
Published: (2025-02-01)

Middle-aged dogs with low and high Aβ CSF concentrations show differences in energy and stress related metabolic profiles in CSF
by: Herman Borghys, et al.
Published: (2024-10-01)

Cerebrospinal Fluid Classical Biomarker Levels in Mixed vs. Pure A<sup>+</sup>T<sup>+</sup> (A<sup>+</sup>T<sub>1</sub><sup>+</sup>) Alzheimer’s Disease
by: Ioanna Tsantzali, et al.
Published: (2024-12-01)

Machine-learning based strategy identifies a robust protein biomarker panel for Alzheimer’s disease in cerebrospinal fluid
by: Xiaosen Hou, et al.
Published: (2025-07-01)

Proteome profiling in cerebrospinal fluid reveals novel biomarkers of Alzheimer's disease
by: Jakob M Bader, et al.
Published: (2020-06-01)

Cerebrospinal fluid levels of tumour necrosis factor-α and its receptors are not associated with disease progression in Alzheimer’s disease
by: Manal Aljuhani
Published: (2025-04-01)

Using cerebrospinal fluid biomarkers to diagnose Alzheimer’s disease: an Australian perspective
by: Dhamidhu Eratne, et al.
Published: (2024-12-01)

Associations between platelet indices and cerebrospinal fluid biomarkers of Alzheimer’s disease pathology in cognitively intact adults: the CABLE study
by: Shi-Yin Xiong, et al.
Published: (2025-05-01)

Sleep disorders and Alzheimer’s disease: relationship and mechanisms involving neuroinflammation, orexin and Aβ
by: Wenjing Zhang, et al.
Published: (2025-06-01)

Diagnostic Challenge in Frontal Variant Alzheimer's Disease With Low Amyloid‐β PET Retention
by: Ryosuke Shimasaki, et al.
Published: (2025-07-01)

The Role of CSF Biomarkers in Discriminating Between Cerebral Amyloid Angiopathy and Alzheimer’s Disease Patients: Systematic Review of Clinical Studies
by: Zahra Razmkhah, et al.
Published: (2024-10-01)

Targeted Magnetic Nanoparticles for Beta-Amyloid Detection
by: Nelly S. Chmelyuk, et al.
Published: (2024-10-01)

Sleep quality, APOE ε4, and Alzheimer’s disease: associations from two prospective cohort studies and mechanisms by plasma proteomic analysis
by: Liang-Yu Huang, et al.
Published: (2025-08-01)

Decrease in p3‐Alcβ37 and p3‐Alcβ40, products of Alcadein β generated by γ‐secretase cleavages, in aged monkeys and patients with Alzheimer's disease
by: Saori Hata, et al.
Published: (2019-01-01)

Multimodal MRI reveals impaired glymphatic function with choroid plexus enlargement and cerebrospinal fluid expansion in alzheimer’s disease
by: Weiqi Lin, et al.
Published: (2025-08-01)

Application of the revised criteria for diagnosis and staging of Alzheimer's disease: Drug development and clinical practice
by: Clifford R. Jack, et al.
Published: (2024-10-01)

Hippocampal subfields: volume, neuropathological vulnerability and cognitive decline in Alzheimer’s and Parkinson’s disease
by: Maud M. A. Bouwman, et al.
Published: (2025-05-01)

Distribution of β-amyloid and pTau in brain cortex depending on age and mental state
by: Alexandra V. Sentyabreva, et al.
Published: (2024-12-01)

APOE GENE POLYMORPHISM: THE IMPACT OF APOE4 ALLELE ON SYSTEMIC INFLAMMATION AND ITS ROLE IN THE PATHOGENESIS OF ALZHEIMER’S DISEASE
by: I. K. Malashenkova, et al.
Published: (2018-06-01)

MicroRNA Signatures Predict Brain Amyloidosis and Neurodegeneration in Alzheimer’s Disease: Insights from [18F] AV45 and FDG PET Imaging
by: Parsa saberian, et al.
Published: (2025-05-01)

Immune cell responses to amyloid-beta proteins: What is the extent and implications of amyloid-beta induced cytotoxicity in microglial cells and peripheral blood mononuclear cells?
by: Cao, A.
Published: (2017-07-01)

Apolipoprotein E imbalance in the cerebrospinal fluid of Alzheimer’s disease patients
by: Matthew Paul Lennol, et al.
Published: (2022-11-01)

Alzheimer's disease and osteoporosis
by: Yu-Hung Chen, et al.
Published: (2017-01-01)

Cerebrospinal fluid proteome profiling across the Alzheimer’s disease continuum: a step towards solving the equation for ‘X’
by: Sophia Weiner, et al.
Published: (2025-05-01)

New Possibilities for Evaluating Markers of Alzheimer's Disease in Blood Serum
by: S. V. Vorobev, et al.
Published: (2025-06-01)

Phototherapy via Modulation of β‐Amyloid in Combating Alzheimer's Disease
by: Yunhua Zhang, et al.
Published: (2025-05-01)

Traumatic Brain Injury and Genetic Risk for Alzheimer’s Disease Impact Cerebrospinal Fluid β-Amyloid Levels in Vietnam War Veterans
by: Jena N. Moody, et al.
Published: (2024-11-01)

Screening of Aβ and phosphorylated tau status in the cerebrospinal fluid through machine learning analysis of portable electroencephalography data
by: Masahiro Hata, et al.
Published: (2025-01-01)

Alzheimer's disease
by: N. N. Koberskaya
Published: (2019-06-01)

Study of the possibility of correcting behavioral disorders in rats with a stereotaxic model of Alzheimer's disease
by: I. I. Semina, et al.
Published: (2023-05-01)

Beneficial Influence of Agomelatine Treatment on Behavioral Impairments in AΒ-Induced Rat Model of Alzheimer’s Disease
by: Kalina Ilieva, et al.
Published: (2020-12-01)

The effects of a bioavailable curcumin formulation on Alzheimer's disease pathologies: A potential risk for neuroinflammation
by: Shaun Cade, et al.
Published: (2024-12-01)

Diagnosis and Treatment of Alzheimer’s Disease: Current Update
by: Younghee Yim, et al.
Published: (2025-01-01)

Late‐midlife lifestyle and brain and cognitive changes in individuals on the AD versus non‐AD continuum
by: Julie E. Oomens, et al.
Published: (2025-04-01)

CD22 modulation alleviates amyloid β-induced neuroinflammation
by: Yu Dong Mai, et al.
Published: (2025-02-01)

MRI-Driven Longitudinal Studies of Hippocampal Alterations During the Initial Cognitive Decline
by: Qunxi Dong, et al.
Published: (2025-01-01)